ENG

EST
RUS

Icosagen

COVID-19
Services
Products
IcoCell
Technologies and R&D
- QMCF Technology & licensing
- EU projects/R&D collaboration
Quality Control Services
- Food microbiology testing services
- Latex allergen testing with FITkit
Contact us
- History
- About us
- Management
- Our team
News

Close menu

Menu

News

News

July 31, 2017

Meet us at AACC 2017 in San Diego

Come and join us for a scientific discussion in booth 5359 at AACC meeting in San Diego.

‹ Back to news

Latest news

Icosagen's SARS-CoV-2 Neutralizing Antibody ELISA Kit Is Available for Evaluating Immune Responses to COVID-19 and Carries an IVD CE Mark
May 07, 2021
BioBlock®, a Novel Prophylactic Nasal Spray With Antibodies Against SARS-CoV-2 Developed by Icosagen, Has Received Marketing Authorization and Is Available for Sale in Estonia
May 04, 2021

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

Contact US Office

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070

Contact EU Office

Recombinant antibody production
Antibody development
Protein production
Expression of membrane proteins

Antibodies
Proteins
ELISA kits
Transfection reagent
Local distributors

Technologies and R&D

QMCF Technology & licensing
EU projects/R&D collaboration

Quality Control Services

Food microbiology testing services
Latex allergen testing with FITkit

History
About us
Management
Our team

Back to top

Icosagen